(Q36118205)

12 August 2017

Recognition and Management of Oral Mucosal Injury Caused by Mammalian Target of Rapamycin Inhibitors: A Case Series (English)

1 reference

12 August 2017

1 reference

Timothy F Meiller

1

1 reference

12 August 2017

Sharon Varlotta

series ordinal

2

1 reference

12 August 2017

Dianna Weikel

series ordinal

3

1 reference

12 August 2017

1 May 2015

1 reference

12 August 2017

Case reports in oncology

1 reference

12 August 2017

8

1 reference

12 August 2017

2

1 reference

12 August 2017

369-377

1 reference

Strategies for the management of adverse events associated with mTOR inhibitors

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

The pros and the cons of mTOR inhibitors in kidney transplantation

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Understanding, recognizing, and managing toxicities of targeted anticancer therapies

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

mTOR signaling pathway and mTOR inhibitors in cancer therapy

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Clinical presentation and management of mTOR inhibitor-associated stomatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Targeting mammalian target of rapamycin (mTOR) for health and diseases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Current development of mTOR inhibitors as anticancer agents

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Recurrent aphthous stomatitis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Preliminary characterization of oral lesions associated with inhibitors of mammalian target of rapamycin in cancer patients

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4592504

Clobetasol ameliorates aphthous ulceration in renal transplant patients on sirolimus

23 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26464573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

1 reference

https://pubmed.ncbi.nlm.nih.gov/26464573

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1159/000438747

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

26464573

1 reference